SCHEMBL3358239

SCHEMBL3358239

CC=C(N)C(=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6378778 1.00
Hydrochloric Acid SCHEMBL27994744 0.97
SCHEMBL21395233 0.82 ALDH1A1 (0.39)
SCHEMBL19123760 0.81 ALDH1A1 (0.35)
SCHEMBL15641382 0.80
SCHEMBL27734554 0.77
SCHEMBL8344089 0.77
SCHEMBL9461969 0.76 HCAR2 (0.43)
SCHEMBL20913012 0.76 ALDH1A1 (0.40)
SCHEMBL20913011 0.76 ALDH1A1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2702035-B1 PROCESS FOR CONTINUOUS FLOW SYNTHESIS OF BETA-AMINO CROTONATE COUNCIL SCIENT IND RES (IN) 2018-03-07 EP claimed
US-9199913-B2 Process for continous flow synthesis of beta-amino crotonate COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-12-01 US claimed
EP-2702035-A2 PROCESS FOR CONTINUOUS FLOW SYNTHESIS OF BETA-AMINO CROTONATE Council of Scientific & Industrial Research (IN) 2014-03-05 EP claimed
US-20140046090-A1 PROCESS FOR CONTINOUS FLOW SYNTHESIS OF beta-AMINO CROTONATE COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2014-02-13 US claimed
WO-2012147103-A2 PROCESS FOR CONTINUOUS FLOW SYNTHESIS OF β-ΑΜΙΝΟ CROTONATE COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2012-11-01 WO claimed
US-6784297-B2 CONDENSING PHTHALIC ANHYDRIDE AND ETHANOLAMINE, COUPLING WITH ETHYL 4-CHLORACETOACETATE/O-CHLOROBENZALDEHYDE, CONDENSING (CYCLIZATION) WITH METHYL AMINOCROTONATE, PURIFYING, HYDROLYZING, SALT FORMING; COMMERCIALLY VIABLE; EFFICIENCY KOPRAN LIMITED (IN) 2004-08-31 US claimed
CN-1326470-A Redox polymerization process AKZO NOBEL NV (NL) 2001-12-12 CN claimed
CN-1056509-C Patches for percutaneous administration of skin-whitening materials PACIFIC CHEM CO LTD (KR) 2000-09-20 CN claimed
CN-1076110-A Percutaneous is given so that the patch of skin-whitening materials PACIFIC CHEM CO LTD (KR) 1993-09-15 CN claimed
EP-4213980-A1 AMINE MODIFIED POLYSACCHARIDE URETHANE/UREA MICROCAPSULES Encapsys, LLC (US) 2023-07-26 EP disclosed
WO-2022061103-A1 AMINE MODIFIED POLYSACCHARIDE URETHANE/UREA MICROCAPSULES ENCAPSYS, LLC (US) 2022-03-24 WO disclosed
EP-2666538-B1 DISPERSING AGENT, DISPERSION, METHOD FOR ADJUSTING VISCOSITY OF DISPERSION, MOBILE DEVICE, SURFACE TREATMENT AGENT, ELECTROLYTIC SOLUTION, SEPARATOR, AND RECHARGEABLE LITHIUM ION BATTERY UNIV FUKUOKA (JP) 2019-04-17 EP disclosed
CN-106831787-B Compound and its preparation method and application as bruton's tyrosine kinase inhibitor 成都倍特药业有限公司 2018-10-23 CN disclosed
CN-105017085-B A kind of kcnq potassium channel agonist, preparation method and use 中国科学院上海药物研究所 2018-06-29 CN disclosed
US-4983740-A Multistep; from 2- 2-/2-chloroethoxy/ethoxy!ethanol and potassium phthalimide ADIR ET COMPAGNIE (FR) 1991-01-08 US disclosed
US-4870091-A CALCIUM CHANNEL BLOCKERS ADIR ET CIE (FR) 1989-09-26 US disclosed
US-4603135-A HYPOTENSIVE AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1986-07-29 US disclosed
US-4593033-A Cardiovascular disorders MERCK & CO., INC. (US) 1986-06-03 US disclosed
EP-0138505-A2 Dihydropyridine derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1985-04-24 EP disclosed
US-4022897-A 4H-PYRIDO(1,2-A) PYRIMIDIN-4-ONE DERIVATIVES E. R. SQUIBB & SONS, INC. (US) 1977-05-10 US disclosed